PDGFD and bladder transitional cell carcinoma: Studies have indicated that PDGFD, a part of the platelet-derived growth factor family, is linked to gemcitabine resistance in BLCA patients and unfavorable prognosis in advanced uroepithelial carcinoma and pancreatic ductal adenocarcinoma (PDAC)64,65.